Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Packer M, Anker S Butler J et al for the EMPEROR-Reduced Trial Investigators
N Engl J Med. 2020 Aug 29.
http://doi.org/10.1056/NEJMoa2022190
Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank
De Jong M, Woodward M and Peters S
Diabetes Care. 2020 Sep;43(9):2050-2059.
http://doi.org/10.2337/dc19-2363
Mechanisms, screening modalities and treatment options for individuals with non-alcoholic fatty liver disease and type 2 diabetes
Hydes TJ, Summers N, Brown E, et al.
Diabet Med. 2020 Jul 3.
http://doi.org/10.1111/dme.14356
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial
Perkovic V.; Toto R, Cooper ME. et al.
Diabetes Care. 2020 Aug; 43(8): 1803–1812.
http://doi.org/10.2337/dc20-0279
High-protein meals require 30% additional insulin to prevent delayed postprandial hyperglycaemia
Paterson MA, Smart CEM, Howley P, Price DA, et al.
Diabet Med. 2020 Jul;37(7):1185-1191.
www.doi.org/10.1111/dme.14308
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC
JAMA. 2020 Jul 10.
www.doi.org/10.1001/jama.2020.12839
Comentarios recientes